June 15, 2021
Article
Results from the first phase of the broad, collaborative MYLUNG research study in lung cancer provide a close-up look at current biomarker testing rates and turnaround times for patients treated in community practices within The US Oncology Network.
February 04, 2021
Article
Therapies targeting oncogenesis and the tumor microenvironment are increasingly replacing chemotherapies as first-line treatments for non–small cell lung cancer.
October 27, 2020
Article
Due to efforts to reduce exposure to the coronavirus, oncology patient volumes initially decreased, treatment regimens were disrupted or altered, and new cancer diagnoses also slowed. This affected not only patient care, but also clinical trials.
October 25, 2020
Article
Much is still unknown about the cancer process and how targeted therapies work on specific tumor vulnerabilities. Providers must closely follow evolving information, especially regarding adverse events.
September 18, 2020
Article
As efforts to reduce exposure to the coronavirus ramped up, nonemergency surgical procedures were halted, screening procedures were delayed, and the amount of new cancer diagnoses declined.